These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3661387)

  • 1. The role of antihypertensive pharmacologic treatment in countering adverse pathophysiological profiles: influence on small arteries.
    Dahlöf B
    Am Heart J; 1987 Oct; 114(4 Pt 2):984-91. PubMed ID: 3661387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of structural cardiovascular changes by antihypertensive therapy.
    Hansson L; Sivertsson R
    Hypertension; 1984; 6(6 Pt 2):III147-9. PubMed ID: 6519754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between cardiac hypertrophy and forearm vascular structural changes before and during long-term antihypertensive treatment.
    Agabiti-Rosei E; Muiesan ML; Geri A; Romanelli G; Montani G; Muiesan G
    Am J Med; 1988 Mar; 84(3A):125-8. PubMed ID: 2975461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of blood pressure and resistance artery structure: potential clinical implications.
    Christensen KL; Buus NH
    Basic Clin Pharmacol Toxicol; 2012 Jan; 110(1):73-9. PubMed ID: 21920026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic effects of metoprolol and pindolol: a comparison in hypertensive patients.
    Svensson A; Gudbrandsson T; Sivertsson R; Hansson L
    Br J Clin Pharmacol; 1982; 13(Suppl 2):259S-267S. PubMed ID: 7104149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular structural alterations in hypertension: effect of treatment.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Clin Exp Hypertens; 1996; 18(3-4):513-22. PubMed ID: 8743039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antihypertensive treatment on small artery remodelling.
    Agabiti-Rosei E; Heagerty AM; Rizzoni D
    J Hypertens; 2009 Jun; 27(6):1107-14. PubMed ID: 19293726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in blood pressure and systemic vascular resistance do not predict microvascular structure during treatment of mild essential hypertension.
    Eftekhari A; Mathiassen ON; Buus NH; Gotzsche O; Mulvany MJ; Christensen KL
    J Hypertens; 2012 Apr; 30(4):794-801. PubMed ID: 22306851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
    Friberg P
    Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review.
    Dahlöf B
    Drugs; 1988; 35 Suppl 5():6-26. PubMed ID: 2975216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance and conduit arteries following converting enzyme inhibition in hypertension.
    Safar ME; van Bortel LM; Struijker-Boudier HA
    J Vasc Res; 1997; 34(2):67-81. PubMed ID: 9167639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
    Ishiguro K; Hayashi K; Sasamura H; Sakamaki Y; Itoh H
    Hypertension; 2009 Jan; 53(1):83-9. PubMed ID: 19047581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic effects of pindolol on the arterioles, large arteries, and veins of the forearm in mild to moderate essential hypertension.
    Maarek B; Simon AC; Levenson J; Merli I; Bouthier J
    Clin Pharmacol Ther; 1986 Apr; 39(4):403-8. PubMed ID: 2937599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of cardiovascular structural changes--a preventive strategy.
    Dahlöf B
    Clin Exp Hypertens A; 1990; 12(5):877-96. PubMed ID: 2145096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary reserve in experimental myocardial hypertrophy.
    Gosse P; Clementy J
    Eur Heart J; 1995 Aug; 16 Suppl I():22-5. PubMed ID: 8829953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of pindolol in essential hypertension with special reference to resistance vessels in the forearm during maximal vasodilatation.
    Gretzer I; Dunér H; Lagerbäck B
    J Hypertens Suppl; 1985 Dec; 3(3):S215-7. PubMed ID: 2856707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature survey.
    Christensen KL; Mulvany MJ
    J Hypertens; 2001 Jun; 19(6):1001-6. PubMed ID: 11403346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.